Company Name: |
BOC Sciences
|
Tel: |
16314854226 |
Email: |
info@bocsci.com |
Products Intro: |
Product Name:Taprostene CAS:108945-35-3 Purity:95% Package:1G;10G;100G Remarks:Taprostene is a prostacyclin (PGI2) analog that acts as an agonist of the prostacyclin receptor, IP.
|
Company Name: |
Shanghai Hongye Biotechnology Co. Ltd
|
Tel: |
400-9205774 |
Email: |
sales@glpbio.cn |
Products Intro: |
Product Name:Taprostene (free acid) CAS:108945-35-3 Purity:>98% Package:1mg;10mg;50mg;100mg;
|
Company Name: |
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
|
Tel: |
18818260767 |
Email: |
sales@chemegen.com |
Products Intro: |
Product Name:Taprostene free acid CAS:108945-35-3 Purity:98% Package:10 mg;50 mg;100 mg;500 mg;1 g;5 g;10 g
|
Company Name: |
Hubei Xinyang Medical Technology Co., Ltd
|
Tel: |
15347293736 15347293736 |
Email: |
2853117764@qq.com |
Products Intro: |
Product Name:Taprostene CAS:108945-35-3 Purity:99% HPLC Package:10mg;25mg;50mg;100mg
|
|
| Taprostene Basic information |
Product Name: | Taprostene | Synonyms: | 3-[[[(2Z,3aR,6aβ)-4β-[(1E,3S)-3-Cyclohexyl-3-hydroxy-1-propenyl]hexahydro-5α-hydroxy-2H-cyclopenta[b]furan]-2-ylidene]methyl]benzoic acid;Taprostene;Taprostene (free acid);Taprostene (free acid) Exclusive;Benzoic acid, 3-[(Z)-[(3aR,4R,5R,6aS)-4-[(1E,3S)-3-cyclohexyl-3-hydroxy-1-propen-1-yl]hexahydro-5-hydroxy-2H-cyclopenta[b]furan-2-ylidene]methyl]- | CAS: | 108945-35-3 | MF: | C24H30O5 | MW: | 398.49 | EINECS: | | Product Categories: | | Mol File: | 108945-35-3.mol | |
| Taprostene Chemical Properties |
Boiling point | 609.4±55.0 °C(Predicted) | density | 1.305±0.06 g/cm3(Predicted) | solubility | Water: 25 mg/ml | form | A crystalline solid | pka | 4.03±0.10(Predicted) |
| Taprostene Usage And Synthesis |
Description | Taprostene is a stable prostacyclin (PGI2) analog and agonist of the prostacyclin receptor, IP. It does not activate the PGE2 receptor EP4, which, like IP, promotes vascular smooth muscle relaxation when stimulated. Taprostene has been used extensively to study the role of the IP receptor in tissue preparations and in vivo. It has also been used in the screening and evaluation of potential IP antagonists. |
| Taprostene Preparation Products And Raw materials |
|